Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008;8(3):430-3.
doi: 10.1007/s12028-008-9062-2.

Baclofen and gamma-hydroxybutyrate withdrawal

Jennifer L LeTourneau  1 , Daniel S Hagg, Stephen M Smith
Affiliations
Case Reports

Baclofen and gamma-hydroxybutyrate withdrawal

Jennifer L LeTourneau et al. Neurocrit Care. 2008.

Abstract

Introduction: Benzodiazepine treatment of life-threatening gamma-hydroxybutyrate (GHB) withdrawal is frequently unsatisfactory. Animal studies suggest strongly that treatment with GABA(B) agonists, such as baclofen, will be a more effective strategy.

Methods: A case report from the medical intensive care unit (ICU) of the university tertiary care hospital.

Results: A 61-year-old woman was admitted to the medical ICU for severe withdrawal symptoms from chronic GHB use. This manifested as delirium, tremor, and seizures despite only small decreases in GHB dose and treatment with benzodiazepines. The addition of baclofen allowed the rapid sequential decreases in the GHB dose without seizure or delirium and resulted in long-term improvement of her tremor.

Conclusions: Baclofen, a GABA(B) agonist, may be a useful agent in the treatment of severe GHB withdrawal.

PubMed Disclaimer

References

    1. Teter CJ, Guthrie SK. A comprehensive review of MDMA, GHB: two common club drugs. Pharmacotherapy. 2001;21(12):1486–513. - PubMed
    1. Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol. 2002;40(2):129–35. - PubMed
    1. Snead OC, III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med. 2005;352(26):2721–32. - PubMed
    1. Fuller DE, Hornfeldt CS. From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy. 2003;23(9):1205–9. - PubMed
    1. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med. 2005;1(4):391–7. - PubMed

Publication types

MeSH terms